Amgen AMGN is off to a strong start in 2025 with its first-quarter earnings as well as sales beating estimates. Particularly, ...

President Trump on Monday signed a series of health-focused executive actions, including one cracking down on ...

Chinese officials have long used their willingness to cooperate to stem the flow of fentanyl to the United States as leverage ...

Roche posted higher first-quarter sales that beat analysts’ expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs. To strengthen its U.S ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

This key feature differentiates it from Eli Lilly and Novo Nordisk’s popular GLP-1-based obesity drugs, Zepbound and Wegovy, which are weekly injections. In March, Amgen initiated two phase III ...

Roche posted higher first-quarter sales that beat analysts' expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...